Treatment Planning Expansions in Glioblastoma: How Less Can Be More

Daniel M Trifiletti¹, Michael T Milano², Kristin J Redmond³, Erqi L Pollom⁴, Jona A Hattangadi-Gluth⁵, Michelle M Kim⁶

Affiliations

¹ Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida. Electronic address: trifiletti.daniel@mayo.edu.
² Department of Radiation Oncology, University of Rochester, Rochester, New York.
³ Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
⁴ Department of Radiation Oncology, Stanford University, Stanford, California.
⁵ Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
⁶ Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

PMID: 37652602
DOI: 10.1016/j.ijrobp.2023.03.062

Editorial

Treatment Planning Expansions in Glioblastoma: How Less Can Be More

Daniel M Trifiletti et al. Int J Radiat Oncol Biol Phys. 2023.

. 2023 Oct 1;117(2):293-296.

doi: 10.1016/j.ijrobp.2023.03.062.

Authors

Daniel M Trifiletti¹, Michael T Milano², Kristin J Redmond³, Erqi L Pollom⁴, Jona A Hattangadi-Gluth⁵, Michelle M Kim⁶

Affiliations

¹ Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida. Electronic address: trifiletti.daniel@mayo.edu.
² Department of Radiation Oncology, University of Rochester, Rochester, New York.
³ Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
⁴ Department of Radiation Oncology, Stanford University, Stanford, California.
⁵ Department of Radiation Medicine and Applied Sciences, University of California, San Diego, La Jolla, California.
⁶ Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

PMID: 37652602
DOI: 10.1016/j.ijrobp.2023.03.062

No abstract available

PubMed Disclaimer

Comment on

Initial Results of a Phase 2 Trial of ¹⁸F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma.
Laack NN, Pafundi D, Anderson SK, Kaufmann T, Lowe V, Hunt C, Vogen D, Yan E, Sarkaria J, Brown P, Kizilbash S, Uhm J, Ruff M, Zakhary M, Zhang Y, Seaberg M, Wan Chan Tseung HS, Kabat B, Kemp B, Brinkmann D. Laack NN, et al. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1383-1395. doi: 10.1016/j.ijrobp.2021.03.032. Epub 2021 Mar 23. Int J Radiat Oncol Biol Phys. 2021. PMID: 33771703 Clinical Trial.
Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis.
Minniti G, Tini P, Giraffa M, Capone L, Raza G, Russo I, Cinelli E, Gentile P, Bozzao A, Paolini S, Esposito V. Minniti G, et al. Radiother Oncol. 2023 Apr;181:109435. doi: 10.1016/j.radonc.2022.11.024. Epub 2022 Dec 16. Radiother Oncol. 2023. PMID: 36529439
Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide.
Mendoza MG, Azoulay M, Chang SD, Gibbs IC, Hancock SL, Pollom EL, Adler JR, Harraher C, Li G, Gephart MH, Nagpal S, Thomas RP, Recht LD, Jacobs LR, Modlin LA, Wynne J, Seiger K, Fujimoto D, Usoz M, von Eyben R, Choi CYH, Soltys SG. Mendoza MG, et al. Pract Radiat Oncol. 2023 May-Jun;13(3):e239-e245. doi: 10.1016/j.prro.2023.01.008. Epub 2023 Feb 2. Pract Radiat Oncol. 2023. PMID: 36736621 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Treatment Planning Expansions in Glioblastoma: How Less Can Be More

Affiliations

Treatment Planning Expansions in Glioblastoma: How Less Can Be More

Authors

Affiliations

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources